<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Immunological phenotyping of mononuclear cell suspensions from bone marrow and/or peripheral blood from 2341 patients (6140 examinations) suspected of malignant haematological diseases was performed during a 10-year period </plain></SENT>
<SENT sid="1" pm="."><plain>The cells were labelled with a panel of monoclonal antibodies and subjected to flowcytometry </plain></SENT>
<SENT sid="2" pm="."><plain>The results showed a clear distinction between <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath>, and a new group of <z:hpo ids='HP_0011009'>acute</z:hpo> hybrid <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (3.3% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> cases) was established </plain></SENT>
<SENT sid="3" pm="."><plain>During the 10-year period immunological phenotyping has changed from being a research method to a widely employed method for cell characterisation early in the course of malignant haematological diseases </plain></SENT>
</text></document>